Enalapril Maleate Tablets, USP, 20 mg, 1,000-count bottle, Rx only, Manufactured by: Unique Pharmaceutical Laboratories (A Div. of J.B. Chemicals & Pharmaceuticals Ltd.), Mumbai 400 030, India, Distributed by: Rising Pharma Holdings, Inc., East Brunswick, NJ 08816, NDC 64980-688-10.
Published May 13, 2026 · Recall initiated: April 23, 2026
Summary
FDA records drug Class II recall D-0520-2026, published May 13, 2026 and initiated April 23, 2026. Recalling firm: JB Chemicals and Pharmaceuticals Ltd; Status: Ongoing; Reported quantity: 675 bottles; Lot: Lot #: GEH25023, Expires: 6/30/2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Impurities/Degradation Specifications:Out of specification result occurred in Organic Impurities Test
What to do
Voluntary: Firm initiated · Letter
Get an email if ENALAPRIL MALEATE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- ENALAPRIL MALEATE
- Manufacturer
- JB Chemicals and Pharmaceuticals Ltd
- Distributor
- Nationwide in the USA
- Lot
- Lot #: GEH25023, Expires: 6/30/2027
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- India
Related recalls
- FDAOctreotide Acetate for Injectable Suspension, for gluteal intramuscular use, 30 mg, In Single-Dose kitsMay 13, 2026
- FDADuloxetine Delayed-Release Capsules USP, 60mg, Rx Only, 90-count bottle, Mfr. by Towa Pharmaceutical EurpoeMay 13, 2026
- FDAEnalapril Maleate Tablets, USP; 2.5 mg; 90 tablets, NDC 60429-183-90; manufactured by Taro PharmaceuticalJuly 13, 2022
- FDAEnalapril Maleate Tablets, USP; 10 mg; 90 tablets, NDC 60429-185-90; manufactured by Taro PharmaceuticalJuly 13, 2022
- FDAEnalapril Maleate Tablets, USP; 5 mg; 90 tablets, NDC 60429-184-90; manufactured by Taro PharmaceuticalJuly 13, 2022
- FDAEnalapril Maleate Tablets, USP; 20 mg; 90 tablets, NDC 60429-186-90; manufactured by Taro PharmaceuticalJuly 13, 2022
Questions about this recall
Was Enalapril Maleate Tablets, USP, 20 mg, 1,000-count bottle, Rx only, Manufactured by: Unique Pharmaceutical Laboratories (A Div. of J.B. Chemicals & Pharmaceuticals Ltd.), Mumbai 400 030, India, Distributed by: Rising Pharma Holdings, Inc., East Brunswick, NJ 08816, NDC 64980-688-10. recalled?
Yes. FDA published recall D-0520-2026 on May 13, 2026. Reported hazard: Failed Impurities/Degradation Specifications:Out of specification result occurred in Organic Impurities Test
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: ENALAPRIL MALEATE.